Following Biologic Treatment Outcomes in Stricturing Crohn's Disease
Studies how biologic medicines work in people with narrowing Crohn's disease.
Plain-language title generated from the registry record
Registry title: Biologics for Stricturing Crohn's Diseases
Key facts
- Where
- Nanjing, ChinaSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 16 and 65 years old?
Source: NCT05645055, who can take part
Where in China
- Department of General Surgery, Jinling hosptal,Medical School of Nanjing UniversityNanjing, ChinaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Jinling Hospital, China
- Trial code
- NCT05645055
- Record updated
- 11 May 2023
- Original description
Recent researches have reported that biologics might be also effective for stricturing CD. However, the data were largely retrospective. Prospective studied are needed for evaluate the efficacy of biologics for stricturing Crohn's diseases.Read full original descriptionShow less
The Clinical Outcomes of Patients With Stricturing Crohn's Diseases Received Biologics: a Prospective, Observative Study
Recent researches have reported that biologics might be also effective for stricturing CD. However, the data were largely retrospective. Prospective studied are needed for evaluate the efficacy of biologics for stricturing Crohn's diseases.
Inclusion: patients with stricturing Crohn's diseases; no surgical indication; patients with asymptomatic penetrating diseases; written consent acquired.
Exclusion: patients with surgical indication; patients with symptomatic penetrating diseases; contraindication of biologics; anticipating other trial.